Frenova
Frenova is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research and its adjacent conditions. As a Fresenius Medical Care North America company, Frenova manages clinical research assets and resources including over 450 principal investigators at more than 260 sites representing 160 medical practices. Frenova’s F1RST Up® network of select investigative sites provides sponsors with accelerated study startup, while Frenova’s SMO manages clinical research staff and streamlines trial operations to help investigators enroll more patients and perform more studies.